Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03042546 · ClinicalTrials.gov registry record · Phase 4
Calcium Sulfate Spacer in Open Tibia Fractures
A Phase 4 study, sponsored by University of Washington.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT03042546 is a Phase 4 study that was terminated before completion, run by University of Washington. The registered enrollment target is 1 participants.
The verdict
NCT03042546, a Phase 4 study, was terminated before completion, sponsored by University of Washington.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
Investigators will compare antibiotic impregnated Calcium sulfate versus PMMA versus nothing in these sub-segmental bone defects.
Interventions
- OTHER No treatment
- DRUG Calcium Sulfate
- DRUG PMMA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2018-05-29 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03042546
The ClinicalTrials.gov registry entry for NCT03042546 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which No treatment is the first listed.
NCT03042546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03042546 about?
NCT03042546 is a clinical study titled "Calcium Sulfate Spacer in Open Tibia Fractures". Investigators will compare antibiotic impregnated Calcium sulfate versus PMMA versus nothing in these sub-segmental bone defects.
What is the current status of trial NCT03042546?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2017-02-01. Estimated completion is 2018-05-29.
What interventions are being tested in trial NCT03042546?
The interventions under investigation include: No treatment (OTHER), Calcium Sulfate (DRUG), PMMA (DRUG).
Who is sponsoring clinical trial NCT03042546?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.